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Human POT1 Facilitates Telomere
Elongation by Telomerase
dynamics in either telomerase-positive or telomerase-
negative cells.
First, we transfected a mass culture of telomerase-
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1Children’s Medical Research Institute positive HT1080 cells, derived from a human fibrosar-
coma, with three hPOT1 splice variants (Figure 1A). Sta-214 Hawkesbury Road
Westmead, NSW 2145 ble clones were isolated, and expression of hPOT1
mRNA was verified (see the Supplemental Data availableAustralia
2 Stowers Institute for Medical Research with this article online). HT1080/hPOT1 clones and vec-
tor control clones were cultured in vitro for a total of 401000 East 50th Street
Kansas City, Missouri 64110 population doublings (PDs). After this time, DNA was
isolated for analysis of terminal restriction fragment3 Howard Hughes Medical Institute
Department of Chemistry and Biochemistry (TRF) length by Southern blotting [12]. Mean telomere
lengths were quantitated from autoradiographs by usingUniversity of Colorado
Boulder, Colorado 80309 Telometric software [13]. We found that telomeres were
significantly elongated in 11 of 31 hPOT1 clones, but
there was no elongation in 10 vector control clones ex-
amined (Figure 1B; Supplemental Data). ElongatedSummary
HT1080/hPOT1 clones showed an average mean telo-
mere length of 14 kb (4 kb), an increase of 8 kb whenMammalian telomeric DNA is mostly composed of
compared with the average mean telomere length of 6double-stranded 5-TTAGGG-3 repeats and ends with
kb (1 kb) seen in HT1080 vector control clones. Thea single-stranded 3 overhang. Telomeric proteins sta-
increase in hybridization intensity observed for thebilize the telomere by protecting the overhang from
hPOT1 clones with longer telomeres provided indepen-degradation [1, 2] or by remodeling the telomere into a
dent evidence that the lengthening was due to an in-T loop structure [3]. Telomerase is a ribonucleoprotein
creased number of telomeric DNA repeats.that synthesizes new telomeric DNA [4, 5]. In budding
While all three splice variants of hPOT1 tested wereyeast, other proteins, such as Cdc13p, that may help
able to lengthen telomeres, splice variants 1 and 2maintain the telomere end by regulating the recruit-
seemed to have a higher percentage of clones elongatedment or local activity of telomerase have been identi-
(5/11 and 4/10 clones, respectively) compared withfied [6–9]. Pot1 is a single-stranded telomeric DNA
splice variant 3 (2/10 clones). Not all clones expressingbinding protein first identified in fission yeast, where
hPOT1 exhibited telomere elongation, but variability init was shown to protect telomeres from degradation
the effects of exogenously expressed genes is often[10]. Human POT1 (hPOT1) protein is known to bind
seen in immortalized human cells and presumably re-specifically to the G-rich telomere strand [11]. We now
flects clonal variation in the activity of interactingshow that hPOT1 can act as a telomerase-dependent,
factors.positive regulator of telomere length. Three splice vari-
ants of hPOT1 were overexpressed in a telomerase-
positive human cell line. All three variants lengthened
hPOT1 in a Clonal Population of HT1080
telomeres, and splice variant 1 was the most effective.
Because of the variability in telomere length after trans-
hPOT1 was unable to lengthen the telomeres of telo-
fection with hPOT1, for further analyses, we chose to
merase-negative cells unless telomerase activity was
use a single clone of HT1080 rather than the parental
induced. These data suggest that a normal function
mass culture. This clone was isolated by transfection
of hPOT1 is to facilitate telomere elongation by telo-
with pIRESneo vector (Clontech), followed by stable se-
merase.
lection, and was designated HT1080 neo-4. Each of the
three hPOT1 splice variants was separately transfected
Results and Discussion into the HT1080 neo-4 clone, and stable subclones were
isolated.
hPOT1 Elongates Telomeres in Telomerase- Telomere lengths were determined by Southern blot-
Positive Cells ting, and we saw telomere elongation with two of the
Pot1 protein has been shown to bind to the G-rich tail three hPOT1 splice variants (Figure 2; Supplemental
of eukaryotic chromosomes and to protect the telo- Data). The average mean telomere length of vector con-
meres of fission yeast from rapid degradation [10]. Our trol subclones was 6 kb (2 kb), while the elongated
aim was to determine what role hPOT1 might have in hPOT1 subclones had a mean telomere length of 12 kb
human cells. In this study, we examined whether exoge- (3 kb). Overall, 7 of 30 HT1080 neo-4/hPOT1 subclones
nous expression of hPOT1 has an effect on telomere had elongated telomeres; due to the lack of any effect
by variant 2, this proportion is smaller than that seen
with the HT1080 parental culture. Expression of splice*Correspondence: rreddel@cmri.usyd.edu.au
4These authors contributed equally to this work variant 1 was associated with telomere elongation in
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Figure 1. Lengthening of Telomeres by Hu-
man Pot1 Expression Plasmids
(A) Five splice variants of human POT1
(hPOT1) have been characterized, and the re-
sultant proteins vary in their ability to bind
telomeric DNA in vitro [11]. The three variants
used in these experiments are shown here.
Variant 2 had the greatest affinity for telo-
meric DNA, followed by variant 1 and 3, in
that order. The black boxes indicate protein
sequence derived from alternative exon
usage.
(B) Telomere lengths in HT1080 clones ex-
pressing hPOT1 variants. hPOT1 splice vari-
ants 1–3 were subcloned into pIRESneo and
pIRESpuro vectors (Clontech). In all experi-
ments analyzing hPOT1 transfectants, cells
were also transfected with pCIneo (Stra-
tagene), pIRESpuro (Clontech), or pPUR
(Clontech) vectors as a control. Cells were
transfected with 5 g plasmid DNA by using
Fugene-6 transfection reagent (Roche) as
previously described [22]. Colonies were
picked after 2 weeks of selection on Geneticin
(G418 sulfate, Roche) and/or puromycin (Cal-
biochem) and were maintained in appropriate
drug selection thereafter. Terminal restriction
fragment (TRF) length analysis was per-
formed as described [12].
5/10 subclones, compared with 2/10 subclones for vari- ure 1A). Variant 1 encodes the full-length protein, while
variant 2 is predicted to encode a protein missing theant 3. These proportions were similar to that seen with
the HT1080 parental culture. However, variant 2 had no C-terminal half of variant 1. Variant 2 has a greater DNA
binding affinity, yet its effects were less consistent thandetectable effect on HT1080 neo-4 (0/10 clones had
elongated telomeres). In light of this variability, splice those of variant 1; so, it appears that the C-terminal
portion of the latter may facilitate telomere elongation.variant 2 was not examined in some of the subsequent
experiments. Nevertheless, we conclude that hPOT1 Variant 3 encodes more of the C terminus than variant
2, yet it is less effective at telomere elongation. Varianthas the ability to lengthen telomeres in the telomerase-
positive HT1080 cell line and in a clone of HT1080. 3 is also the most inefficient at binding telomeric DNA
[11]. Therefore, it seems that telomere elongation byAn explanation for the differences in activity between
hPOT1 variants may lie in protein domain structure (Fig- hPOT1 may involve both telomeric DNA binding and an
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Telomere Lengthening by hPOT1 Is
Telomerase Dependent
If hPOT1-induced telomere lengthening is telomerase
dependent, then hPOT1 should have no effect in telo-
merase-negative cells. To test this, the telomerase-neg-
ative immortal cell line, GM847, was stably transfected
with each of the three hPOT1 splice variants. Telomere
lengths in hPOT1-transfected and control clones were
measured at 24 and 60 PDs. There was no detectable
change in mean telomere length at either time point (see
the Supplemental Data).
To confirm that hPOT1-mediated telomere lengthen-
ing is telomerase dependent, we expressed hTERT and
hPOT1 together in GM847 cells. We have previously
generated GM847 clones expressing hTERT and have
shown that exogenous expression of hTERT reconsti-
tutes telomerase activity in these cells and can lengthen
the shortest telomeres [14]. For this study, we trans-
fected GM847-hTERT cells with each of the hPOT1
splice variants or a vector control. RT-PCR analyses
verified that the resulting clones all expressed hTERT
and that the hPOT1-transfected clones expressed
hPOT1 mRNA (not shown).
We found that hPOT1 increases the efficiency of
hTERT-induced telomere lengthening in GM847 cells.
Telomere lengths were examined by Southern hybridiza-
tion, and while there were no significant differences in
mean telomere length, the hPOT1-transfected clones
had elongated the shortest telomeres. This elongation
results in a partial homogenization of the telomere
lengths that is manifest by more intense hybridization
at approximately 19 kb (Figure 4). Quantitation with Te-
lometric software [13] confirmed the results of visual
inspection of the Southern blots. While only 2/9 hTERT-
expressing control clones had a mode telomere length
above 12 kb, 11/14 clones expressing both hTERT and
hPOT1 had a mode significantly higher than 12 kb
(mode  17–23 kb).
Figure 2. Telomere Lengths in HT1080 Neo-4 Subclones Expressing The observation that hPOT1 was able to increase
Vector Control or hPOT1 Splice Variant 1 GM847 telomere length only in the presence of hTERT
A mass culture (MC) of hPOT1 variant 1-expressing cells is also indicates that hPOT1-mediated telomere elongation is
included. The mass culture and many of the individual subclones telomerase dependent.
expressing variant 1 had elongated telomeres relative to the vector
control (indicated by a “”).
hPOT1 and Telomere Maintenance
The human telomere is thought to exist in at least two
states: “open” and “closed.” It is proposed that the
unknown function provided by the C terminus of the “closed” conformation protects the telomere end from
protein. degradation and inappropriate DNA repair that would
result in chromosome end-to-end fusions. In mamma-
lian cells, this state is most likely to involve T loop forma-
hPOT1 Does Not Increase Telomerase Activity tion [15]. According to the T loop model, however, in
To determine whether the elongated telomeres seen certain stages of the cell cycle the telomere would need
in a number of HT1080/hPOT1 clones were a result of to be in a more “open” conformation to permit access
increased telomerase activity, telomerase activity in se- of telomerase [16, 17].
rially diluted lysates of elongated HT1080/hPOT1 clones One possible role for hPOT1 protein is to bind the 3
was compared with vector control clones (Figure 3). end of human telomeres and stabilize the telomeres
There was no detectable increase in in vitro telomerase while in the “open” configuration. Additionally, it is pos-
activity in elongated HT1080/hPOT1 clones compared sible that when hPOT1 is overexpressed it competes
with control clones. This result indicates that telomere for binding the telomere end, displacing the T loop and
elongation by POT1 is not due to an overall increase in leaving more telomeres in the “open” conformation. This
telomerase activity, but does not exclude the possibility might allow telomerase greater access to the telomere
and result in increased telomere lengths; this proposedof a localized activation of telomerase at the telomere.
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Figure 3. In Vitro Telomerase Activity in HT1080 Clones Expressing Vector Control or hPOT1 Variant1
The PCR-based TRAP assay for telomerase activity was performed as described [23], except that products were stained with SYBR Green I
(Molecular Probes) and were visualized with a Storm 860 imager (Molecular Dynamics). Myogenin DNA (0.1 fg) with TRAP primer flanking
sequences was used as an internal control in each reaction [24]. Protein lysis buffer was used as the negative control (LB). For each clone,
10-fold serial dilutions of protein lysate were used in the activity assay. The dilution at which telomerase activity is undetectable can be used
to compare telomerase activity between clones. For both vector control and hPOT1-transfected clones, telomerase activity was undetectable
only at the highest dilution. Therefore, there was no significant difference in telomerase activity after the addition of hPOT1.
role is consistent with our results showing a telomerase- Cdc13p binds single-stranded telomeric DNA, and dele-
tion of the CDC13 gene also results in rapid loss ofdependent telomere elongation by hPOT1. Alternatively,
hPOT1 may inhibit a negative regulator of telomerase telomeric DNA [18]. Cdc13p appears to recruit telo-
merase to the telomere or to activate telomerase atactivity.
hPOT1 may also actively recruit the telomerase com- the telomere [6, 9, 19]. Direct binding of Cdc13p to the
telomerase complex has been demonstrated, in thatplex to the end of the telomere. Although there is no
sequence similarity, there are many parallels between Cdc13p has been shown to interact with Est1p, a protein
that associates with the RNA component of telomerasePot1 and the S. cerevisiae protein, Cdc13p. Like Pot1,
Figure 4. GM847 Cells with Reconstituted
Telomerase Activity Show Increased Telo-
mere Elongation after Expression of hPOT1
Splice Variants
GM847 cells expressing hTERT were gener-
ated previously [14]. GM847/hTERT-6 was
stably transfected with empty vector or
hPOT1 variants in a puromycin-selectable
plasmid. The telomere lengths in the resultant
clones were analyzed by pulse-field gel elec-
trophoresis and TRF analysis [12]. Only two
empty vector control clones had telomeres
elongated by the reconstituted telomerase
activity; this frequency is similar to that seen
previously with GM847/hTERT-6 (unpub-
lished data). However, most clones express-
ing hPOT1 variants had elongated telomeres
(indicated by a “”). Therefore, hPOT1 is able
to increase the efficiency of hTERT-induced
telomere lengthening in GM847 cells.
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meres and telomerase in hTERT-transfected GM847 cells. Mol.[6, 20, 21]. It will be interesting to determine whether
Cell. Biol. 21, 3862–3875.hPOT1 parallels Cdc13p in this regard as well. If this is
15. Griffith, J.D., Comeau, L., Rosenfield, S., Stansel, R.M., Bianchi,the case, hPOT1 may be a useful target for anti-cancer
A., Moss, H., and de Lange, T. (1999). Mammalian telomeres
therapeutic agents aimed against telomerase-positive end in a large duplex loop. Cell 97, 503–514.
malignancies. 16. Blackburn, E.H. (2001). Switching and signaling at the telomere.
Cell 106, 661–673.It seems clear that hPOT1 is involved in telomere
17. Smogorzewska, A., van Steensel, B., Bianchi, A., Oelmann, S.,maintenance, and in at least some contexts this includes
Schaefer, M.R., Schnapp, G., and de Lange, T. (2000). Controltelomerase-dependent telomere lengthening. Further
of human telomere length by TRF1 and TRF2. Mol. Cell. Biol.studies are needed to determine the mechanism of this
20, 1659–1668.
effect and whether hPOT1 also functions to protect hu- 18. Garvik, B., Carson, M., and Hartwell, L. (1995). Single-stranded
man chromosomes from degradation. DNA arising at telomeres in cdc13 mutants may constitute a
specific signal for the RAD9 checkpoint. Mol. Cell. Biol. 15,
Supplemental Data 6128–6138.
Supplemental Data including hPOT1 expression analyses and telo- 19. Nugent, C.I., Hughes, T.R., Lue, N.F., and Lundblad, V. (1996).
mere length data are available at http://images.cellpress.com/ Cdc13p: a single-strand telomeric DNA binding protein with a
supmat/supmatin.htm. dual role in yeast telomere maintenance. Science 274, 249–252.
20. Qi, H., and Zakian, V.A. (2000). The Saccharomyces telomere-
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